Human Relaxin 1 + 2 peptide (ab53454)
Key features and details
- Purity: > 95% HPLC
- Suitable for: ELISA
Description
-
Product name
Human Relaxin 1 + 2 peptide -
Purity
> 95 % HPLC. -
Animal free
No -
Nature
Synthetic -
-
Species
Human -
Sequence
ELVRAQIAICGMST -
Additional sequence information
The synthetic peptide is identical for both SwissProt ID: P04808 and P04090. Human Relaxin 2 B chain (aa 14-27). Human Relaxin 1 B chain (aa 16-29).
-
Specifications
Our Abpromise guarantee covers the use of ab53454 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
ELISA
-
Form
Lyophilized -
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Constituent: 0.1% Acetic acid
-
ReconstitutionResuspend in 0,1% acetic acid for required concentration
General Info
-
Alternative names
- Relaxin H1
- Relaxin H2
- RLN1
see all -
Relevance
Relaxin is a peptide hormone produced by the corpora lutea of ovaries during pregnancy in many mammalian species, including man. The secretion of the hormone into the blood stream just before parturition results in a marked softening and lengthening of the pubic symphysis and a softening of the cervix, which facilitates the birth process. By inhibiting uterine contractions, relaxin may influence the timing of parturition. Like insulin, relaxin consists of two peptide chains, A and B, covalently linked by disulfide bonds. By further analogy to insulin, the two peptides are synthesized as a single-chain precursor polypeptide with the B chain at the NH2-terminus. -
Cellular localization
Secreted
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
Datasheet download
References (0)
ab53454 has not yet been referenced specifically in any publications.